SCHEMBL9023213

SCHEMBL9023213

O=Cc1c[nH]c2ccc(Oc3ccccc3)cc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.66
CYP1A2 P05177 1/20 0.66
CYP2C19 P33261 1/20 0.66
CYP2A6 P11509 2/20 0.56
IMPDH2 P12268 1/20 0.56
TRPM8 Q7Z2W7 1/20 0.55
PIK3CA P42336 1/20 0.53
MTOR P42345 1/20 0.53
HTR1D P28221 2/20 0.51
HTR1B P28222 2/20 0.51
MAPT P10636 3/20 0.50
KDM4E B2RXH2 1/20 0.50
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
LTA4H P09960 4/20 0.45
PLA2G2A P14555 4/20 0.45
ICMT O60725 1/20 0.45
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2537557 0.88 ALDH1A1 (0.66) ALDH1A1CYP1A2CYP2C19CYP2A6IMPDH2
SCHEMBL2539105 0.85 ALDH1A1 (0.58) ALDH1A1CYP1A2CYP2C19CYP2A6IMPDH2
SCHEMBL13548682 0.82 ALDH1A1 (0.70) ALDH1A1CYP1A2CYP2C19CYP2A6IMPDH2
SCHEMBL1791105 0.80 MEN1 (0.60) ALDH1A1CYP1A2CYP2C19IMPDH2TRPM8
SCHEMBL1093746 0.80 ALDH1A1 (1.00) ALDH1A1CYP1A2CYP2C19CYP2A6IMPDH2
SCHEMBL20629258 0.79 ALDH1A1 (0.58) ALDH1A1CYP1A2CYP2C19CYP2A6IMPDH2
SCHEMBL29055655 0.76 TRPM8 (0.58) TRPM8PIK3CAMTORHTR1DHTR1B
SCHEMBL2531595 0.76 CYP2A6 (0.61) ALDH1A1CYP1A2CYP2C19CYP2A6IMPDH2
SCHEMBL25978455 0.76 TRPM8 (0.62) ALDH1A1TRPM8PIK3CAMTORHTR1D
SCHEMBL14572611 0.76 ALDH1A1 (0.70) ALDH1A1CYP1A2CYP2C19CYP2A6IMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0548250-B1 SUBSTITUTED BICYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY RHONE POULENC RORER INT (US) 1996-03-27 EP disclosed
US-5468898-A Substituted naphthylene compounds exhibiting selective leukotriene B4 antagonist activity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-11-21 US disclosed
EP-0548250-A4 SUBSTITUTED BICYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY 1993-10-27 EP disclosed
EP-0548250-A1 SUBSTITUTED BICYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY. RHONE POULENC RORER INT (US) 1993-06-30 EP disclosed
WO-1992004321-A1 SUBSTITUTED BICYCLIC ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-03-19 WO disclosed